Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Cardiol ; 92(4): 480-3, 2003 Aug 15.
Article in English | MEDLINE | ID: mdl-12914887

ABSTRACT

Left ventricular anatomic substrates predisposing the development of congestive heart failure in infants with atrial left-to-right shunting after aortic coarctation repair were characterized. Mitral valve, but not aortic or left ventricular, hypoplasia correlated with the development of heart failure and the need for atrial defect closure shortly after coarctation repair.


Subject(s)
Aortic Coarctation/complications , Heart Septal Defects, Atrial/surgery , Mitral Valve/pathology , Aortic Coarctation/pathology , Aortic Coarctation/surgery , Aortic Valve/pathology , Female , Heart Failure/etiology , Heart Septal Defects, Atrial/complications , Heart Septal Defects, Atrial/pathology , Humans , Infant , Infant, Newborn , Male , Postoperative Complications , Retrospective Studies
2.
J Infect Dis ; 185(5): 686-90, 2002 Mar 01.
Article in English | MEDLINE | ID: mdl-11865427

ABSTRACT

Development of a vaccine for prevention of congenital cytomegalovirus (CMV) disease is a priority. This study evaluated a "prime-boost" strategy by comparing the safety and immunogenicity of 3 doses of subunit CMV glycoprotein B (gB) vaccine plus MF59 (a squalene-in-water emulsion), 2 doses of a canarypox recombinant vaccine expressing CMVgB (ALVAC-CMVgB) followed by 2 doses of the subunit gB vaccine, 3 doses of both vaccines administered concomitantly, and placebo in 105 healthy, CMV-seronegative adults. Systemic adverse events were rare, but local reactions were common in all groups. After the first subunit vaccination, neutralizing antibody titers in the prime-boost group were comparable to those in subjects receiving 2 subunit vaccinations, indicating a priming effect of ALVAC-CMVgB. However, after the final dose, antibody and cell-mediated immune responses were not significantly different among the groups. All 3 vaccine regimens induced high-titer antibody and lymphoproliferative responses, but no benefit for priming or simultaneous vaccination was detected.


Subject(s)
Antibodies, Viral/blood , Cytomegalovirus Infections/prevention & control , Cytomegalovirus Vaccines/immunology , Lymphocyte Activation , Vaccines, Subunit/immunology , Viral Envelope Proteins/immunology , Adjuvants, Immunologic/administration & dosage , Adolescent , Adult , Cytomegalovirus Vaccines/administration & dosage , Humans , Immunization Schedule , Immunization, Secondary , Middle Aged , Polysorbates/administration & dosage , Squalene/administration & dosage , Squalene/immunology , Vaccination , Vaccines, Subunit/administration & dosage , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism , Viral Vaccines/administration & dosage , Viral Vaccines/genetics , Viral Vaccines/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...